Uncategorized

VivaChek Glucose Ketone Meter Adds Bluetooth for Telehealth

Addressing the Connectivity Question in Modern Glucose and Ketone Monitoring

Telehealth programs increasingly depend on devices that can share data beyond the bedside, and search queries for a "4G cellular blood glucose meter for telehealth programs" reflect a real need: clinicians and patients want test results to move easily from a handheld meter into a connected care workflow. Based on the available product information, the VivaChek Blood Glucose and β-Ketone Dual System, developed by Weice Biotech under the VivaChek brand, is built around a different but related connectivity approach—optional Bluetooth Low Energy version 5.1—rather than 4G cellular technology. For telehealth-oriented users evaluating connected monitoring tools, understanding exactly what this device offers, and how its dual-testing design addresses common point-of-care pain points, is essential before making a decision.

The Industry Pain Point VivaChek Was Built to Solve

According to VivaChek’s corporate positioning, blood glucose and ketone monitoring has traditionally required separate test strips, separate meters, manual coding, larger blood samples, and limited data connectivity. These friction points add cost, complicate routine testing, and can introduce errors. VivaChek’s strategic response is a one-meter, one-strip dual testing system for blood glucose and β-ketone, featuring auto coding and an optional Bluetooth data management pathway. This positioning directly targets the kind of simplification that remote monitoring and telehealth programs are looking for: fewer supplies, fewer manual steps, and a clearer path for data to leave the device.

Core Value Proposition: One Fingerstick, Two Results

The differentiated advantages of the VivaChek system center on consolidating two tests into a single action. A single test strip measures both blood glucose and β-ketone, with auto coding automatically reading each strip’s coding information to reduce setup error. Testing takes about 12 seconds and requires only about 1.6 microliters of sample. The meter supports a wide hematocrit range of 20–65%, which helps maintain result consistency across a broader range of users. For data connectivity, the device offers an optional Bluetooth Low Energy version 5.1 connection to the VivaChek GlucoKet App, along with a USB Type-C rechargeable battery. Together, these elements support VivaChek’s stated value proposition: simplifying metabolic monitoring by delivering glucose and ketone results from one fingerstick, with fewer supplies, fewer steps, and faster feedback.

Technical Capabilities Behind the Dual-Testing Design

The system is built on an electrochemical biosensor platform, using glucose dehydrogenase for glucose detection and β-hydroxybutyrate dehydrogenase for β-ketone detection. Key technical metrics include a glucose measurement range of 20–600 mg/dL and a β-ketone measurement range of 0.1–8.0 mmol/L, with plasma-equivalent result calibration. The sample type is fresh capillary whole blood, applied via wicking action, end-fill, typically from the fingertip.

Operating conditions span 45.5°F–113°F (7.5°C–45°C) and 10–90% R.H. non-condensing, while test strips should be stored at 36°F–86°F (2°C–30°C). Unopened strips carry a 24-month shelf life, and opened strips are rated for 6 months. The meter is powered by a rechargeable 250 mAh, 3.7 Volt DC nominal, lithium polymer battery with a 5V input charge voltage, and it automatically shuts off 120 seconds after the last action to conserve power. Additional functional features include a beep function, backlight, and hypo warning, while the device does not include test averaging, a strip ejector, ketone warning, meal markers, or test alarms.

In terms of analytical performance, meter results clustered along the fitted regression line with strong linearity, an R² greater than 0.96 and a slope of approximately 1, with no obvious bias. Glucose results specifically showed an R² of 0.97 with a slope near 1, and β-ketone results showed an R² of 0.996, a slope near 1, and an intercept near 0.

D1da0905d6e44aff2e27731cb9d57124

Data Capabilities Relevant to Remote and Telehealth Use

For programs evaluating connected monitoring tools, the relevant data specifications are as follows: the meter stores 300 records with date and time, and when the optional Bluetooth module is enabled, it connects via Bluetooth Low Energy to the VivaChek GlucoKet App for data processing. This Bluetooth-based pathway—rather than 4G cellular—is the connectivity method described in VivaChek’s platform compatibility information, alongside a USB Type-C charging port that reflects an emphasis on modern, widely available charging standards.

Product Features That Support Everyday Monitoring

The VivaChek Blood Glucose and β-Ketone Dual System is positioned for point-of-care use by individuals managing diabetes, metabolic health, or ketosis risk. Its dual measurement capability removes the need for separate strips or meters, while auto coding lowers the risk of coding error. The glucose range of 20–600 mg/dL covers low to high values, and the β-ketone range of 0.1–8.0 mmol/L supports monitoring from normal to severe ketosis. The small sample size and 12-second testing time are designed to make routine testing more manageable, and the wide hematocrit range of 20–65% is intended to reduce the effect of hematocrit variation on results.

The product documentation also includes interpretation guidance: fasting glucose is categorized as normal below 100 mg/dL, prediabetes at 100–125 mg/dL, high at or above 126 mg/dL, and low below 70 mg/dL. β-ketone levels are categorized as normal below 0.6 mmol/L, mild elevation at 0.6–1.5 mmol/L, moderate ketosis at 1.5–3.0 mmol/L, and severe ketosis above 3.0 mmol/L. These reference points are drawn from the American Diabetes Association, Standards of Care in Diabetes—2023 and the International Society for Pediatric and Adolescent Diabetes, Clinical Practice Consensus Guidelines: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.

Business Scope and Delivery Model

VivaChek’s business scope covers point-of-care blood glucose and β-ketone monitoring for individuals tracking these levels. The delivery model is a hardware meter paired with disposable test strips, with an optional Bluetooth Low Energy connection to a companion app—the GlucoKet App—for those who want their records accessible beyond the device itself.

A Practical Note for Telehealth-Focused Buyers

For organizations specifically requiring 4G cellular transmission, it is important to note that the VivaChek Blood Glucose and β-Ketone Dual System’s documented connectivity is an optional Bluetooth Low Energy version 5.1 link to the VivaChek GlucoKet App, not a cellular data connection. What the device does offer for telehealth-adjacent use is a dual-analyte design that reduces testing steps, a 300-record memory with date and time stamps, and an app-based data pathway for those who choose the Bluetooth-enabled version—features that may still support simplified remote monitoring workflows where Bluetooth-to-smartphone data transfer is an acceptable connectivity method.

https://www.vivachek.com
Hangzhou Weice Biotech Co., Ltd.